Type(s) of biological/targeted therapy-Bortezomib Posts on Medivizor
Navigation Menu

Type(s) of biological/targeted therapy-Bortezomib Posts on Medivizor

Minimal residual disease and its association with transplant success in Multiple Myeloma.

Posted by on Jan 27, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study monitored the development of minimal residual disease (MRD) after transplant for multiple myeloma (MM). The main finding was that different patterns of MRD development are associated with varying success after stem cell transplant for MM. Some background There are many treatments for MM. Patients are often cured fully by...

Read More